Day 2 - Friday 4th September 2026

13th RWE, MARKET ACCESS, PRICING & REIMBURSEMENT World Congress 2026 Europe

Powering Market Access Through Real-World Evidence, Digital Innovation & Value-Based Strategies
Friday 4th September 2026
Copthorne Tara Hotel London Kensington, London, UK

Patient-Centric Value, Outcomes & Advanced Therapies

  • Patient-reported outcomes (PROs) in HTA
  • Equity and access disparities
  • Outcomes-based agreements
  • Value frameworks beyond clinical endpoints

Moderator:


Panelist:

  • Role of patient-reported outcomes (PROs)
  • Incorporating patient voice in HTA frameworks
  • Measuring quality of life and functional outcomes
  • Barriers to adoption across Europe
  • Structuring outcomes-based reimbursement contracts
  • Data collection and performance tracking
  • Operational and administrative challenges
  • Scalability across multiple markets
  • Evidence limitations in small populations
  • High upfront costs and payer concerns
  • Regulatory and HTA complexities
  • Access disparities across countries
  • Annuity and staged payment models
  • Risk-sharing agreements
  • Linking payment to long-term outcomes
  • Financial sustainability considerations

 

  • Post-launch evidence requirements
  • Use of registries and longitudinal data
  • Demonstrating durability of treatment effect
  • Supporting re-assessment and reimbursement
  • Patient journey and unmet need
  • Access barriers and solutions implemented
  • Outcomes measurement approach
  • Impact on access and patient outcomes

Digital Transformation, Data & the Future of Market Access

  • Leveraging predictive analytics for pricing and reimbursement decisions
  • Scenario modelling to optimise launch and access strategies
  • AI-driven insights to strengthen payer engagement and negotiations
  • Challenges, limitations, and governance of AI in decision-making
  • Expanding beyond traditional data: wearables, apps, and remote monitoring
  • Validating digital endpoints for regulatory and HTA acceptance
  • Integrating new data streams into evidence generation strategies
  • Opportunities and risks in using patient-generated health data
  • Overcoming fragmentation across national health data systems
  • Advancing interoperability standards and cross-border data sharing
  • Role of European data initiatives and collaborations
  • Public-private partnerships enabling scalable data ecosystems
  • Navigating GDPR and evolving European data regulations
  • Ethical considerations in secondary use of health data
  • Digital platforms for payer and stakeholder engagement
  • Ensuring transparency, trust, and security in data-driven access models
  • Transitioning from static evidence to real-time, data-driven decision-making in pricing and reimbursement
  • The growing role of AI and advanced analytics in shaping market access and payer negotiations
  • Overcoming data fragmentation and interoperability challenges across European healthcare systems
  • Balancing innovation with regulation, GDPR compliance, and ethical use of health data
  • Ensuring equitable, patient-centric access in an increasingly digital and data-driven ecosystem

Moderator:


Panelists:

Day 1 Agenda
Scroll to Top